Analysis of Tumor Incidence in Balb/c Mice Used as Controls in Carcinogenicity Experiments
Open Access
- 1 December 1979
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 65 (6) , 665-675
- https://doi.org/10.1177/030089167906500602
Abstract
The tumor incidence was studied in 4 groups of BALB/c mice kept under observation in the same experimental conditions as untreated controls in the course of bioassays of chemical carcinogenesis. Two parameters that reflect the variations of environmental factors were studied: body growth and survival rate. Their possible influence on tumor incidence was also considered. Fluctuations were observed in the incidence of different tumor types among the groups, but the level of significance was reached only when comparing the incidence of hepatomas, adrenal cortex tumors and subcutaneous fibrosarcomas among males and the incidence of angiomas and angiosarcomas among females. No association was found between the variations of tumor incidence and body growth and survival rate, which remained constant among the groups.This publication has 7 references indexed in Scilit:
- Statistical Issues in Interpretation of Chronic Bioassay Tests for CarcinogenicityJNCI Journal of the National Cancer Institute, 1979
- Carcinogenicity study of rifampicin in mice and ratsToxicology and Applied Pharmacology, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Editorial: Guidelines on the analysis of tumour rates and death rates in experimental animalsBritish Journal of Cancer, 1974
- Mortality Rate and Spontaneous Lesions Found in 2,928 Untreated BALB/cCr Mice2JNCI Journal of the National Cancer Institute, 1968
- Factors in the Causation of Spontaneous Hepatomas in MiceJNCI Journal of the National Cancer Institute, 1966